TELA Bio (TELA) Change in Acquisitions & Divestments (2020)
TELA Bio's (TELA) quarterly Change in Acquisitions & Divestments came in at $5.3 million in Q2 2020, up 32.22% quarter-over-quarter from $4.0 million in Q1 2020.
TELA Bio (TELA) Change in Acquisitions & Divestments (2020) Analysis & Trends
TELA Bio's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $5.3 million for Q2 2020.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $5.3 million in Q2 2020; TTM through Dec 2020 was $9.3 million, a N/A change from a year earlier, with the FY2020 full-year figure at $9.3 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments improved to $5.3 million in Q2 2020 per TELA's latest filing, from $4.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $5.3 million in Q2 2020 and bottomed at $4.0 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | TELA Bio | 38.36 Mn | -1.18 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 5.29 Mn |
| Jun 30, 2020 | 5.29 Mn |
| Mar 31, 2020 | 4.00 Mn |
| Mar 31, 2020 | 4.00 Mn |